Skip to main content
. 2016 Sep 9;12(2):213–218. doi: 10.1007/s11481-016-9705-6

Table 2.

Comparison between patients with and without immunosuppressive medicationa

Characteristic immunosuppressive medication + immunosuppressive medication – P-value
Age (years) 65 (19–91) 61 (17–94) 0.002
Female 30/87 (34) 674/1348 (50) 0.006
Symptoms and signs on admission
 Headache 56/78 (72) 962/1161 (83) 0.02
 Neck stiffness 51/85 (60) 945/1261 (75) 0.005
 Triad of fever, neck stiffness, and change in mental status 31/86 (36) 543/1283 (42) 0.26
 Absence of fever, neck stiffness, and change in mental status 7/87 (8) 43/1334 (3) 0.03
Predisposing factorsb 23/87 (26) 266/1348 (20) 0.13
Distant focus of infection 25/82 (30) 581/1289 (45) 0.01
Blood chemistry testsc
 Leukocyte count (×109/L) 13.9 (0.1–45.6) 17.1 (0.1–99.8) 0.0001
 C-reactive protein (mg/L) 163 (3–500) 192 (0–752) 0.28
Indexes of inflammation in CSFd
 Leukocyte count (cells/mm3) 1368 (5–46,500) 2560 (0–463,149) 0.003
 Leukocyte count <1000 cells/mm3 39/85 (46) 401/1234 (32) 0.02
 Protein (g/L) 3.00 (0.45–11.0) 4.00 (0.02–50.0) P < 0.0005
 CSF/blood glucose ratio 0.17 (0.0–0.89) 0.04 (0.0–1.67) 0.003
Causative organism
Streptococcus pneumoniae 37/87 (43) 981/1348 (73) P < 0.0001
Listeria monocytogenes 35/87 (40) 43/1348 (3) P < 0.0001
Haemophilus influenzae 6/87 (7) 44/1348 (3) 0.12
Neisseria meningitidis 2/87 (2) 147/1348 (11) 0.006
 Othere 7/87 (8) 133/1348 (10) 0.71
Outcome
 Unfavorable outcome 39/87 (45) 495/1348 (37) 0.14
 Mortality 22/87 (25) 219/1348 (16) 0.04
 Neurological sequelae 18/53 (34) 360/997 (36) 0.88

CSF cerebrospinal fluid

aData are presented as n/N (%), or median (range)

bOther than immunosuppressive medication

cLeukocyte count was known in 86 and 1327 episodes and C-reactive protein in 85 and 1283

dCSF leukocyte count was known in 85 and 1234 episodes, CSF protein levels in 85 and 1275 episodes, and CSF blood to glucose ratio in 77 and 1249 episodes

eSee Table 2 for details of causative organisms